THEORETICAL-STUDY OF THE INFLUENCE OF THE CIRCADIAN-RHYTHM OF PLASMA-PROTEIN BINDING ON CISPLATIN AREA UNDER THE CURVE

被引:11
作者
HECQUET, B [1 ]
SUCCHE, M [1 ]
机构
[1] UNIV SCI & TECH LILLE, UER MATH, F-59650 VILLENEUVE DASCQ, FRANCE
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1986年 / 14卷 / 01期
关键词
D O I
10.1007/BF01059285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A mathematical model for area under the curve (AUC) determination is proposed taking into account the circadian variation of cisplatin protein binding. The main theoretical result obtained with the model is that early morning drug administration (2-4 AM) promotes the highest AUC. The model predicts a maximum AUC variation, due to the binding variation, ranging between 2.4 and 15%. The minimum of AUC between 2.45 and 3.30 PM is in agreement with the minimum nephrotoxicity observed when cisplatin is injected in the afternoon. The model can be applied to other drugs that are irreversively bound to proteins or irreversively bound to other plasma components if the binding rate depends on the time of day. The variation intensity of AUC was demonstrated to depend on drug characteristics, but can never be higher than the circadian variation of the protein binding rate.
引用
收藏
页码:79 / 93
页数:15
相关论文
共 19 条
[1]   EFFECTS OF JET LAG ON HORMONAL PATTERNS .1. PROCEDURES, VARIATIONS IN TOTAL PLASMA-PROTEINS, AND DISRUPTION OF ADRENOCORTICOTROPIN-CORTISOL PERIODICITY [J].
DESIR, D ;
VANCAUTER, E ;
FANG, VS ;
MARTINO, E ;
JADOT, C ;
SPIRE, JP ;
NOEL, P ;
REFETOFF, S ;
COPINSCHI, G ;
GOLSTEIN, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (04) :628-641
[2]   PHARMACOKINETICS AND PROTEIN-BINDING OF CIS-DICHLORODIAMMINE PLATINUM (II) ADMINISTERED AS A ONE-HOUR OR AS A 20-HOUR INFUSION [J].
GULLO, JJ ;
LITTERST, CL ;
MAGUIRE, PJ ;
SIKIC, BI ;
HOTH, DF ;
WOOLLEY, PV .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :21-26
[3]  
HECQUET B, 1985, CANCER TREAT REP, V69, P79
[4]  
HECQUET B, 1984, ANN REV CHRONOPHARMA, P115
[5]   CLINICAL KINETICS OF INTACT CISPLATIN AND SOME RELATED SPECIES [J].
HIMMELSTEIN, KJ ;
PATTON, TF ;
BELT, RJ ;
TAYLOR, S ;
REPTA, AJ ;
STERNSON, LA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :658-664
[6]  
HRUSHESKY WJM, 1982, CANCER RES, V42, P945
[7]   CIRCADIAN TIME-DEPENDENCE OF CISPLATIN URINARY KINETICS [J].
HRUSHESKY, WJM ;
BORCH, R ;
LEVI, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :330-339
[8]  
LEVI F, 1982, CANCER TREAT REP, V66, P1933
[9]  
LEVI FA, 1982, CANCER RES, V42, P950
[10]   LETHAL NEPHROTOXICITY AND HEMATOLOGIC TOXICITY OF CIS-DIAMMINEDICHLOROPLATINUM AMELIORATED BY OPTIMAL CIRCADIAN TIMING AND HYDRATION [J].
LEVI, FA ;
HRUSHESKY, WJM ;
HALBERG, F ;
LANGEVIN, TR ;
HAUS, E ;
KENNEDY, BJ .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (05) :471-477